“REDUCTION IN CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS WITH SAROGLITAZAR IN NAFLD: A PROSPECTIVE ANALYSIS”. 2025. International Research Journal of Pharmacy 16 (2): 38-49. https://doi.org/10.56802/y0zhqk37.